Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Stratton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
BMC Rheumatology|March 28, 2025
A case of digital vasculitis in anti-synthetase syndrome (Anti-OJ subtype)Deniz Ak, Richard J Stratton
Matrix Biology : Journal of the International Society for Matrix Biology|January 30, 2025
George R. Martin: Pioneering matrix biologistAndrew Leask, Richard J Stratton
Nature Reviews. Rheumatology|October 3, 2023
Back to the future: targeting the extracellular matrix to treat systemic sclerosisAndrew Leask, Angha Naik, Richard J Stratton
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|September 26, 2024
Digital ulcers associated with scleroderma: A major unmet medical needAngha Naik, Richard J Stratton, Andrew Leask
Rheumatology (Oxford, England)|December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblastsXu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Journal of Cell Communication and Signaling|January 5, 2021
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblastsXu Shi-Wen, Michael Racanelli, Aaisham Ali, et al.
Plos One|October 20, 2017
Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblastsHannah Murphy-Marshman, Katherine Quensel, Xu Shi-Wen, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Annals of the Rheumatic Diseases|June 16, 2023
<i>Tripterygium wilfordii</i> derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosisPratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, et al.
Matrix Biology Plus|February 5, 2021
CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosisKatherine Quesnel, Xu Shi-Wen, James Hutchenreuther, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Rheumatology|March 28, 2025
A case of digital vasculitis in anti-synthetase syndrome (Anti-OJ subtype)Deniz Ak, Richard J Stratton
Matrix Biology : Journal of the International Society for Matrix Biology|January 30, 2025
George R. Martin: Pioneering matrix biologistAndrew Leask, Richard J Stratton
Nature Reviews. Rheumatology|October 3, 2023
Back to the future: targeting the extracellular matrix to treat systemic sclerosisAndrew Leask, Angha Naik, Richard J Stratton
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|September 26, 2024
Digital ulcers associated with scleroderma: A major unmet medical needAngha Naik, Richard J Stratton, Andrew Leask
Rheumatology (Oxford, England)|December 17, 2009
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblastsXu Shi-wen, Mark Eastwood, Richard J Stratton, et al.
Journal of Cell Communication and Signaling|January 5, 2021
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblastsXu Shi-Wen, Michael Racanelli, Aaisham Ali, et al.
Plos One|October 20, 2017
Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblastsHannah Murphy-Marshman, Katherine Quensel, Xu Shi-Wen, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Annals of the Rheumatic Diseases|June 16, 2023
<i>Tripterygium wilfordii</i> derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosisPratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, et al.
Matrix Biology Plus|February 5, 2021
CCN1 expression by fibroblasts is required for bleomycin-induced skin fibrosisKatherine Quesnel, Xu Shi-Wen, James Hutchenreuther, et al.
Pageof 2